Head and Neck Cancers

Latest News

Graphic that resembles a stamp of approval reading "FDA Approved"
FDA Approves Perioperative Pembrolizumab in Head and Neck SCC

June 12th 2025

The FDA approved a perioperative pembrolizumab regimen in head and neck squamous cell carcinoma, marking the first approval in this cancer type in 6 years.

Anatomical graphic of the head and neck with organs visible
Adding Nivolumab to Chemo/RT Yields Higher DFS in Head/Neck Cancer

June 1st 2025

Graphic reading "FDA Approved" resembling a stamp of approval
Belzutifan Granted FDA Approval for Pheochromocytoma or Paraganglioma

May 14th 2025

Light blue line illustration of a person's nasal cavity on a dark blue background
Eftilagimod Alfa/Pembrolizumab May Improve OS in HNSCC With CPS < 1

May 5th 2025

Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background
A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

May 1st 2025

Latest CME Events & Activities

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

View More

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

View More

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

View More

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

View More

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

View More